Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | AKT1 | P31749 | 1/20 | 0.51 |
| ▸ | DGKA | P23743 | 1/20 | 0.49 |
| ▸ | GJB2 | P29033 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19958459 | 0.89 | TLR4 (0.63) | TLR4AKT1GJB2 | |
| SCHEMBL12837376 | 0.89 | TLR4 (0.63) | TLR4AKT1GJB2 | |
| SCHEMBL13449598 | 0.89 | TLR4 (0.63) | TLR4AKT1GJB2 | |
| Trehalose SCHEMBL9058515 | 0.87 | GJB2 (0.53) | TLR4MAPK1AKT1GJB2 | |
| SCHEMBL14166276 | 0.85 | MAPK1 (0.53) | MAPK1DGKA | |
| SCHEMBL3393533 | 0.84 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4199470 | 0.84 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL4185394 | 0.84 | LGALS8 (0.50) | TLR4GJB2 | |
| SCHEMBL3393530 | 0.84 | GJB2 (0.50) | TLR4GJB2 | |
| SCHEMBL3388845 | 0.84 | GJB2 (0.50) | TLR4GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1011609-A4 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORP (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1011609-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MedLogic Global Corporation (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1998050005-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |